Use of proven therapies in non–ST-elevation acute coronary syndromes according to evidence-based risk stratification

Author:

Oliveira Gustavo B.F.,Avezum Alvaro,Anderson Frederick A.,Budaj Andrzej,Dabbous Omar H.,Goodman Shaun G.,Steg Philippe Gabriel,Goldberg Robert J.,Brieger David,Fox Keith A.A.,Gore Joel M.,Granger Christopher B.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference34 articles.

1. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials;Boersma;Lancet,2002

2. The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease;Sabatine;Am J Med,2000

3. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina;Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators;N Engl J Med,1998

4. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non–Q-wave myocardial infarction;Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators;N Engl J Med,1998

5. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes;The PURSUIT Trial Investigators;N Engl J Med,1998

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3